DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,510 | +3.6% | 13,416 | +0.2% | 0.04% | +13.9% |
| Q2 2023 | $3,212,400 | -3.7% | 13,385 | +1.1% | 0.04% | -10.0% |
| Q1 2023 | $3,337,010 | -7.3% | 13,240 | -2.3% | 0.04% | -9.1% |
| Q4 2022 | $3,598,034 | -0.2% | 13,556 | -2.9% | 0.04% | -10.2% |
| Q3 2022 | $3,604,000 | -1.3% | 13,955 | -3.1% | 0.05% | +2.1% |
| Q2 2022 | $3,652,000 | -12.9% | 14,404 | +0.7% | 0.05% | 0.0% |
| Q1 2022 | $4,195,000 | -11.8% | 14,300 | -1.0% | 0.05% | -7.7% |
| Q4 2021 | $4,754,000 | +2.7% | 14,450 | -5.0% | 0.05% | -5.5% |
| Q3 2021 | $4,631,000 | -43.7% | 15,212 | -21.7% | 0.06% | +14.6% |
| Q2 2021 | $8,220,000 | +221.5% | 19,427 | +71.0% | 0.05% | +45.5% |
| Q1 2021 | $2,557,000 | -3.3% | 11,362 | -4.6% | 0.03% | -10.8% |
| Q4 2020 | $2,645,000 | -0.6% | 11,907 | -3.6% | 0.04% | -11.9% |
| Q3 2020 | $2,660,000 | +23.0% | 12,353 | +1.1% | 0.04% | +13.5% |
| Q2 2020 | $2,162,000 | +27.2% | 12,224 | -0.5% | 0.04% | +5.7% |
| Q1 2020 | $1,700,000 | -10.3% | 12,281 | -0.6% | 0.04% | +12.9% |
| Q4 2019 | $1,896,000 | -0.2% | 12,351 | -6.1% | 0.03% | -6.1% |
| Q3 2019 | $1,899,000 | +1.0% | 13,151 | 0.0% | 0.03% | -2.9% |
| Q2 2019 | $1,880,000 | -10.2% | 13,151 | -17.0% | 0.03% | -12.8% |
| Q1 2019 | $2,093,000 | +23.4% | 15,851 | -3.6% | 0.04% | +8.3% |
| Q4 2018 | $1,696,000 | -3.9% | 16,445 | +1.2% | 0.04% | +9.1% |
| Q3 2018 | $1,765,000 | +10.2% | 16,245 | +0.1% | 0.03% | +3.1% |
| Q2 2018 | $1,602,000 | -4.4% | 16,233 | -5.1% | 0.03% | -5.9% |
| Q1 2018 | $1,675,000 | -14.5% | 17,107 | -18.9% | 0.03% | -10.5% |
| Q4 2017 | $1,958,000 | +4.1% | 21,092 | -3.8% | 0.04% | -2.6% |
| Q3 2017 | $1,881,000 | -0.4% | 21,925 | -2.0% | 0.04% | -4.9% |
| Q2 2017 | $1,888,000 | +5.2% | 22,378 | +6.7% | 0.04% | 0.0% |
| Q1 2017 | $1,794,000 | +10.7% | 20,980 | +0.7% | 0.04% | +5.1% |
| Q4 2016 | $1,621,000 | +0.7% | 20,831 | +1.4% | 0.04% | -2.5% |
| Q3 2016 | $1,610,000 | -15.1% | 20,541 | +9.4% | 0.04% | -16.7% |
| Q2 2016 | $1,897,000 | +6.7% | 18,782 | +0.2% | 0.05% | +4.3% |
| Q1 2016 | $1,778,000 | +4.3% | 18,745 | +2.2% | 0.05% | 0.0% |
| Q4 2015 | $1,704,000 | +9.6% | 18,345 | +0.5% | 0.05% | +2.2% |
| Q3 2015 | $1,555,000 | +51.3% | 18,245 | +52.0% | 0.04% | +60.7% |
| Q2 2015 | $1,028,000 | +79.7% | 12,005 | +78.1% | 0.03% | +75.0% |
| Q1 2015 | $572,000 | +44.8% | 6,740 | +46.3% | 0.02% | +45.5% |
| Q4 2014 | $395,000 | +12.5% | 4,606 | -0.4% | 0.01% | +10.0% |
| Q3 2014 | $351,000 | +1.2% | 4,623 | +4.9% | 0.01% | 0.0% |
| Q2 2014 | $347,000 | +4.2% | 4,405 | -0.9% | 0.01% | 0.0% |
| Q1 2014 | $333,000 | -8.5% | 4,445 | -5.6% | 0.01% | 0.0% |
| Q4 2013 | $364,000 | – | 4,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |